Induced pluripotent stem cells (iPSCs) are a seminal breakthrough in stem cell research and are promising tools for advanced regenerative therapies in humans and reproductive biotechnology in farm animals. iPSCs are particularly valuable in species in which authentic embryonic stem cell (ESC) lines are yet not available. Here, we describe a nonviral method for the derivation of bovine iPSCs employing Sleeping Beauty (SB) and piggyBac (PB) transposon systems encoding different combinations of reprogramming factors, each separated by self-cleaving peptide sequences and driven by the chimeric CAGGS promoter. One bovine iPSC line (biPS-1) generated by a PB vector containing six reprogramming genes was analyzed in detail, including morphology, alkaline phosphatase expression, and typical hallmarks of pluripotency, such as expression of pluripotency markers and formation of mature teratomas in immunodeficient mice. Moreover, the biPS-1 line allowed a second round of SB transposon-mediated gene transfer. These results are promising for derivation of germ line–competent bovine iPSCs and will facilitate genetic modification of the bovine genome.
Get full access to this article
View all access options for this article.
References
1.
BaoL., HeL., ChenJ., WuZ., LiaoJ., RaoL., RenJ., LiH., ZhuH., QianL., GuY., DaiH., XuX., ZhouJ., WangW., CuiC., and XiaoL. (2011). Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors. Cell Res., 21, 600–608.
2.
BuganimY., MarkoulakiS., van WietmarschenN., HokeH., WuT., GanzK., Akhtar-ZaidiB., HeY., AbrahamB.J., PorubskyD., KulenkampffE., FaddahD.A., ShiL., GaoQ., SarkarS., CohenM., GoldmannJ., NeryJ.R., SchultzM.D., EckerJ.R., XiaoA., YoungR.A., LansdorpP.M., and JaenischR. (2014). The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. Cell Stem Cell, 15, 295–309.
3.
CaoH., YangP., PuY., SunX., YinH., ZhangY., ZhangY., LiY., LiuY., FangF., ZhangZ., TaoY., and ZhangX. (2012). Characterization of bovine induced pluripotent stem cells by lentiviral transduction of reprogramming factor fusion proteins. Int. J. Biol. Sci., 8, 498–511.
4.
CaoS., WangF., ChenZ., LiuZ., MeiC., WuH., HuangJ., LiC., ZhouL., and LiuL. (2009). Isolation and culture of primary bovine embryonic stem cell colonies by a novel method. J. Exp. Zool. A Ecol. Genet. Physiol., 311, 368–376.
5.
CarlsonD.F., TanW., HackettP.B., and FahrenkrugS.C. (2013). Editing livestock genomes with site-specific nucleases. Reprod. Fertil. Dev., 26, 74–82.
6.
ClarkJ., and WhitelawB. (2003). A future for transgenic livestock. Nat. Rev. Genet., 4, 825–833.
7.
CoroadinhaA.S., Gama-NortonL., AmaralA.I., HauserH., AlvesP.M., and CruzP.E. (2010). Production of retroviral vectors: Review. Curr. Gene Ther., 10, 456–473.
8.
DavisR.P., NemesC., VargaE., FreundC., KosmidisG., GkatzisK., de JongD., SzuhaiK., DinnyesA., and MummeryC.L. (2013). Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system. Differentiation, 86, 30–37.
9.
DengY., LiuQ., LuoC., ChenS., LiX., WangC., LiuZ., LeiX., ZhangH., SunH., LuF., JiangJ., and ShiD. (2012). Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors. Stem Cells Dev., 21, 2485–2494.
10.
EstebanM.A., XuJ., YangJ., PengM., QinD., LiW., JiangZ., ChenJ., DengK., ZhongM., CaiJ., LaiL., and PeiD. (2009). Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J. Biol. Chem., 284, 17634–17640.
11.
GarrelsW., MatesL., HollerS., DaldaA., TaylorU., PetersenB., NiemannH., IzsvakZ., IvicsZ., and KuesW.A. (2011). Germline transgenic pigs by Sleeping Beauty transposition in porcine zygotes and targeted integration in the pig genome. PloS One, 6, e23573.
12.
GarrelsW., IvicsZ., and KuesW.A., (2012a). Precision genetic engineering in large mammals. Trends Biotechnol., 30, 386–393.
13.
GarrelsW., HollerS., CleveN., NiemannH., IvicsZ., and KuesW.A. (2012b). Assessment of fecundity and germ line transmission in two transgenic pig lines produced by sleeping beauty transposition. Genes (Basel), 3, 615–633.
14.
GongG., RoachM.L., JiangL., YangX., and TianX.C. (2010). Culture conditions and enzymatic passaging of bovine ESC-like cells. Cell. Reprogram., 12, 151–160.
15.
GünG., and KuesW.A. (2014). Current progress of genetically engineered pig models for biomedical research. Biores. Open Access, 3, 255–264.
16.
GrabundzijaI., WangJ., SebeA., ErdeiZ., KajdiR., DevarajA., SteinemannD., SzuhaiK., SteinU., CantzT., SchambachA., BaumC., IzsvakZ., SarkadiB., and IvicsZ. (2013). Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. Nucleic Acids Res., 41, 1829–1847.
17.
GrimmD., KernA., RittnerK., and KleinschmidtJ.A. (1998). Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum. Gene Ther., 9, 2745–2760.
18.
HanX., HanJ., DingF., CaoS., LimS.S., DaiY., ZhangR., ZhangY., LimB., and LiN. (2011). Generation of induced pluripotent stem cells from bovine embryonic fibroblast cells. Cell Res., 21, 1509–1512.
19.
HeoY.T., QuanX., XuY.N., BaekS., ChoiH., KimN.H., and KimJ. (2014). CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells. Stem Cells Dev. 24, November3, 2014 [Epub ahead of print].
20.
Hauschild-QuinternJ., PetersenB., CostG.J., and NiemannH. (2013). Gene knockout and knockin by zinc-finger nucleases: current status and perspectives. Cell. Mol. Life Sci., 70, 2969–2983.
21.
HuangB., LiT., Alonso-GonzalezL., GorreR., KeatleyS., GreenA., TurnerP., KallingappaP.K., VermaV., and ObackB. (2011). A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition. PloS One, 6, e24501.
22.
IvicsZ., GarrelsW., MátésL., YauT.Y., BashirS., ZidekV., LandaV., GeurtsA., PravenecM., RülickeT., KuesW.A., and IzsvákZ. (2014). Germline transgenesis in pigs by cytoplasmic microinjection of Sleeping Beauty transposons. Nat. Protoc., 9, 810–827.
23.
JinM., WuA., DorzhinS., YueQ., MaY., and LiuD. (2012). Culture conditions for bovine embryonic stem cell-like cells isolated from blastocysts after external fertilization. Cytotechnology, 64, 379–389.
24.
KohS., and PiedrahitaJ.A. (2014). From “ES-like” cells to induced pluripotent stem cells: A historical perspective in domestic animals. Theriogenology, 81, 103–111.
25.
KuesW.A., and NiemannH. (2011). Advances in farm animal transgenesis. Prev. Vet. Med., 102, 146–156.
KumarD., TalluriT.R., AnandT., and KuesW.A. (2015). Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals. World J. Stem Cells, 26, 315–328.
28.
LiX., BurnightE.R., CooneyA.L., MalaniN., BradyT., SanderJ.D., StaberJ., WheelanS.J., JoungJ.K., McCrayP.B.Jr., BushmanF.D., SinnP.L., and CraigN.L. (2013). piggyBac transposase tools for genome engineering. Proc. Natl. Acad. Sci. USA, 110, E2279–E2287.
29.
LiY., ZhangQ., YinX., YangW., DuY., HouP., GeJ., LiuC., ZhangW., ZhangX., WuY., LiH., LiuK., WuC., SongZ., ZhaoY., ShiY., and DengH. (2011). Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res., 21, 196–204.
30.
LiaoJ., CuiC., ChenS., RenJ., ChenJ., GaoY., LiH., JiaN., ChengL., XiaoH., and XiaoL. (2009). Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell, 4, 11–15.
Malaver-OrtegaL.F., SumerH., LiuJ., and VermaP.J. (2012). The state of the art for pluripotent stem cells derivation in domestic ungulates. Theriogenology, 78, 1749–1762.
33.
MannoC.S., PierceG.F., ArrudaV.R., GladerB., RagniM., RaskoJ.J., OzeloM.C., HootsK., BlattP., KonkleB., DakeM., KayeR., RazaviM., ZajkoA., ZehnderJ., RustagiP.K., NakaiH., ChewA., LeonardD., WrightJ.F., LessardR.R., SommerJ.M., TiggesM., SabatinoD., LukA., JiangH., MingozziF., CoutoL., ErtlH.C., HighK.A., and KayM.A. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med., 12, 342–347.
34.
MaruottiJ., MunozM., DegrelleS.A., GomezE., LouetC., DiezC., de LongchampP.H., BrochardV., HueI., CaamanoJ.N., and JouneauA. (2012). Efficient derivation of bovine embryonic stem cells needs more than active core pluripotency factors. Mol. Reprod. Dev., 79, 461–477.
35.
MeirY.J., LinA., HuangM.F., LinJ.R., WeirauchM.T., ChouH.C., LinS.J., and WuS.C. (2013). A versatile, highly efficient, and potentially safer piggyBac transposon system for mammalian genome manipulations. FASEB J., 27, 4429–4443.
36.
MuenthaisongS., UjhellyO., PolgarZ., VargaE., IvicsZ., PirityM.K., and DinnyesA. (2012). Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer. Exp. Cell Res., 318, 2482–2489.
37.
MunozM., RodriguezA., De FrutosC., CaamanoJ.N., DiezC., FacalN., and GomezE. (2008). Conventional pluripotency markers are unspecific for bovine embryonic-derived cell-lines. Theriogenology, 69, 1159–1164.
OkitaK., NakagawaM., HyenjongH., IchisakaT., and YamanakaS. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949–953.
40.
PlewsJ.R., GuM., LongakerM.T., and WuJ.C. (2012). Large animal induced pluripotent stem cells as pre-clinical models for studying human disease. J. Cell. Mol. Med., 16, 1196–1202.
41.
RenJ., PakY., HeL., QianL., GuY., LiH., RaoL., LiaoJ., CuiC., XuX., ZhouJ., RiH., and XiaoL, (2011). Generation of hircine-induced pluripotent stem cells by somatic cell reprogramming. Cell Res. 21, 849–853.
42.
RosselloR.A., ChenC.C., DaiR., HowardJ.T., HochgeschwenderU., and JarvisE.D. (2013). Mammalian genes induce partially reprogrammed pluripotent stem cells in non-mammalian vertebrate and invertebrate species. eLife, 2, e00036.
43.
RostovskayaM., FuJ., ObstM., BaerI., WeidlichS., WangH., and SmithA.J., AnastassiadisK., and StewartA.F. (2012). Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res., 40, e150.
44.
SaitoS., StrelchenkoN., and NiemannH. (1992). Bovine embryonic stem cell-like cell lines cultured over several passages. Roux's Arch. Dev. Biol., 201, 134–141.
45.
SaitoS., SawaiK., UgaiH., MoriyasuS., MinamihashiA., YamamotoY., HirayamaH., KageyamaS., PanJ., MurataT., KobayashiY., ObataY., and YokoyamaK.K. (2003). Generation of cloned calves and transgenic chimeric embryos from bovine embryonic stem-like cells. Biochem. Biophys. Res. Commun., 309, 104–113.
46.
SeguraM.M., MangionM., GailletB., and GarnierA. (2013). New developments in lentiviral vector design, production and purification. Expert Opin. Bioll. Ther., 13, 987–1011.
47.
ShiY., DespontsC., DoJ.T., HahmH.S., ScholerH.R., and DingS. (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 3, 568–574.
48.
ShimadaH., NakadaA., HashimotoY., ShigenoK., ShionoyaY., and NakamuraT. (2010). Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol. Reprod. Dev., 77, 2.
StadtfeldM., NagayaM., UtikalJ., WeirG., and HochedlingerK. (2008). Induced pluripotent stem cells generated without viral integration. Science, 322, 945–949.
51.
SumerH., LiuJ., Malaver-OrtegaL.F., LimM.L., KhodadadiK., and VermaP.J. (2011). NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts. J. Anim. Sci., 89, 2708–2716.
52.
TakahashiK., and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
53.
TakahashiK., TanabeK., OhnukiM., NaritaM., IchisakaT., TomodaK., and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
54.
TalluriT.R., KumarD., GlageS., GarrelsW., IvicsZ., DebowskiK., BehrR., and KuesW.A. (2014). Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons. Biochem. Biophys. Res. Commun., 450, 581–587.
55.
TanW., CarlsonD.F., LanctoC.A., GarbeJ.R., WebsterD.A., HackettP.B., and FahrenkrugS.C. (2013). Efficient nonmeiotic allele introgression in livestock using custom endonucleases. Proc. Natl. Acad. Sci. USA, 110, 16526–16531.
56.
ThomasC.E., EhrhardtA., and KayM.A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet., 4, 346–358.
57.
TiscorniaG., SingerO., and VermaI.M. (2006). Production and purification of lentiviral vectors. Nat. Protoc., 1, 241–245.
58.
TsukiyamaT., Kato-ItohM., NakauchiH., and OhinataY. (2014). A comprehensive system for generation and evaluation of induced pluripotent stem cells using piggyBac transposition. PloS One, 9, e92973.
59.
VelazquezM.A., KuesW.A., and NiemannH. (2014). Biomedical applications of ovarian transvaginal ultrasonography in cattle. Anim. Biotechnol., 25, 266–293.
60.
VermaR., HollandM.K., Temple-SmithP., and VermaP.J. (2012). Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid. Theriogenology, 77, 220–228, 228.e221–222.
61.
WangS.W., WangS.S., WuD.C., LinY.C., KuC.C., WuC.C., ChaiC.Y., LeeJ.N., TsaiE.M., LinC.L., YangR.C., KoY.C., YuH.S., HuoC., ChuuC.P., MurayamaY., NakamuraY., HashimotoS., MatsushimaK., JinC., EcknerR., LinC.S., SaitoS., and YokoyamaK.K. (2013). Androgen receptor-mediated apoptosis in bovine testicular induced pluripotent stem cells in response to phthalate esters. Cell Death Dis. 4, e907.
62.
WarrenL., ManosP.D., AhfeldtT., LohY.H., LiH., LauF., EbinaW., MandalP.K., SmithZ.D., MeissnerA., DaleyG.Q., BrackA.S., CollinsJ.J., CowanC., SchlaegerT.M., and RossiD.J. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618–630.
WorsdorferP., ThierM., KadariA., and EdenhoferF. (2013). Roadmap to cellular reprogramming—manipulating transcriptional networks with DNA, RNA, proteins and small molecules. Curr. Mol. Med., 13, 868–878.
65.
WuC., and DunbarC.E. (2011). Stem cell gene therapy: The risks of insertional mutagenesis and approaches to minimize genotoxicity. Front. Med., 5, 356–371.
66.
WuX., LiY., CriseB., and BurgessS.M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science, 300, 1749–1751.
67.
WuX., LukeB.T., and BurgessS.M. (2006). Redefining the common insertion site. Virology, 344, 292–295.
68.
YuJ., VodyanikM.A., Smuga-OttoK., Antosiewicz-BourgetJ., FraneJ.L., TianS., NieJ., JonsdottirG.A., RuottiV., StewartR., SlukvinI.I., and ThomsonJ.A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.
69.
YuJ., HuK., Smuga-OttoK., TianS., StewartR., SlukvinI.I., and ThomsonJ.A. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797–801.
70.
ZhouH., WuS., JooJ.Y., ZhuS., HanD.W., LinT., TraugerS., BienG., YaoS., ZhuY., SiuzdakG., ScholerH.R., DuanL., and DingS. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381–384.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
